Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid

Urologia Internationalis

Volumn 59, Issue 1, 1997, Pages 26-29

  Porru, Daniele ^a   Campus, Giuliana ^a   Tudino, Donatella ^a   Valdes, Enrico ^b   Vespa, Alessandro ^b   Scarpa, Roberto M ^a   Usai, Enzo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SS Trinit Hospital   (Italy)

Author keywords

Conservative treatment; Interstitial cystitis; Symptom score; Urodynamics

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONIC ACID;

ADULT; ARTICLE; BLADDER; BLADDER CATHETERIZATION; BLADDER EPITHELIUM; BLADDER WALL; CATHETERIZATION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPITHELIUM; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; INTERSTITIAL CYSTITIS; INTRAVESICAL DRUG ADMINISTRATION; MICTURITION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030861511     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000283012     Document Type: Article

References (19)

1. Hunncr GL: Elusive ulcer of the bladder, Am J Obstet 1918:78:374-377.
2. Sant GR: Interstitial cystitis-pathogenesis, evaluation and treatment, Urology Annual 1990;3:171-174.
3. Sant GR: Interstitial cystitis, Monogr Urol 1991:12:37-40.
4. Hanno PM: Diagnosis of interstitial cystitis, Urol Clin N Am 1994:21:63-66.
5. Ratliff TL, Klutke CG, McDougall EM: The aetiology of interstitial cystitis, Urol Clin N Am 1994:21:21-30.
6. Parsons CL: The therapeutic role of sulfatcd Polysaccharide in urinary' bladder, Urol Clin N Am 1994:21:93-95.
7. Keller ML, McCarthy DO, Neider RS: Measurement of symptoms of interstitial cystitis, Urol Clin N Am 1994:21:67-71.
8. Fall M, Johansson SL, Aldenborg F: Chronic interstitial cystitis: A heterogeneous syndrome, J Urol 1987:137:35-39.
9. Morales A, Emerson L: Treatmcnt of refractory' interstitial cystitis with intravesical hyaluronic acid, JUrof 1995:153:238A.
10. Parsons CL, Mulholland S: Successful therapy of interstitial cystitis with pentosanpolysulfate, J Urol 1987;138:513-516.
11. Wilson CB, Leopard J, Nakamura RM, Cheresh DA, Stein PC, Parsons CL: Selective type IV collagen defects in the urothelial basement membrane in interstitial cystitis, J Urol 1995: 154:1222-1226.
12. Dixon JS, Holm-Bentzen M, Gilpin CJ, Gosling JA, Bostoftc E, Haid T, Larsen S: Electron microscopic investigation of the bladder uro-thelium and glycocalyx in patients with interstitial cystitis, J Urol 1986:135:621-624.
13. Balasz EA, Dcnlinger JL: The effect of hyaluronic acid in arthritis and its therapeutic use: in Pevron JG (ed): ‘Osteoarthritis’: Current Clinical and Fundamental Problems, Basel, Geigy, 1984, pp 165-174.
14. Sato H, Takahashi T, Ide H, Fukushima T, Tabata M, Sekine F, Kobayashi K, Ncgishi M, Niwa Y: Antioxidant activity of sinovial fluid, hyaluronic acid and 2 subcomponents of hyaluronic acid: Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients, Arthritis Rheum 1988:31:63-66.
15. Goldberg RL, Toole BP: Hyaluronic inhibition of cell proliferation, Arthritis Rheum 1987:30: 769-771.
16. Lose G, Frandscn B, Hojensgaard JC, Jespers-en J, Astrup T: Chronic interstitial cystitis: Increased levels of eosinophilic cationic protein in scrum and urine and an ameliorating effect of subcutaneous heparin, Scand J Urol Nephrol 1983:17:159-161.
17. Weave RG, Dougherty TF, Natoli CA: Recent concepts in interstitial cystitis, J Urol 1963:89: 377-383.
18. Morales A, Emerson L, Curtis Nickel J, Lundie M: Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis, J Urol 1996:156:45-48.
19. Messing EM: The diagnosis of interstitial cystitis, Urology 1987;29(suppl):4-7.